Prognostic Stage IIA Breast Cancer AJCC v8 Recruiting Phase 2 / 3 Trials for Paclitaxel (DB01229)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04862585Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelSupportive Care